Global Over-the-Counter (OTC) Veterinary Drugs Market Poised for Remarkable Growth with a Projected CAGR of 7.9% from 2023 to 2033

The global over-the-counter (OTC) veterinary drugs market is on the verge of substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 7.9% from 2023 to 2033. According to recent market analysis, the industry is set to achieve an impressive market share of USD 19.01 billion by 2033, a significant rise from its estimated value of USD 8.8 billion in 2023.

This rapid expansion of the OTC veterinary drugs market is largely attributed to the rising adoption of dogs and cats as beloved family members, a trend that has surged in the post-pandemic era. As more people integrate pets into their households, there is an increasing focus on their nutrition, health, and overall well-being. This evolving pet ownership dynamic is driving the demand for OTC veterinary drugs, which are favored for their convenience and accessibility.

A key factor fueling the market’s growth is the trend among pet owners seeking easy-to-access solutions for their pets’ health needs. The convenience of obtaining OTC veterinary drugs without the need for a veterinarian’s prescription has led to a notable increase in their use. This shift is further supported by recent regulatory changes that have made OTC veterinary drugs more widely available. With evolving legal frameworks promoting self-care for pets, consumers now enjoy greater access to a broader range of veterinary products, simplifying the procurement process and enhancing pet care.

The OTC veterinary drugs market is set to thrive as these trends continue to shape the industry, offering pet owners an accessible and convenient option for maintaining their pets’ health and well-being.

Key Takeaways:

  • The United States market leads the over-the-counter (OTC) veterinary drugs market in terms of market share in North America. The United States region held a market share of 25.6% by 2022. The growth in this region is attributed to higher pet adoption and government efforts. North America dominates the market as it held a 35% global share in 2022.
  • Germany’s over-the-counter (OTC) veterinary drugs market is another significant market in the European region. The market held a market share of 7.9% in 2022. The growth is attributed to the presence of the major OTC veterinary drug producers. Europe held a global share of 32% in 2022.
  • The Indian over-the-counter (OTC) veterinary drugs market thrives at a CAGR of 8.3% during the forecast period. The booming growth rate is attributed to the increasing pet adoption and humanization along with the increasing number of OTC veterinary drug producers in the region.
  • The oral form segment leads the dosage form type segment as it held a market share of 76.40% in 2022. The growth is attributed to lower pain unlike injections, higher effectiveness, and affordability.
  • Based on the sales channel type, the online pharmacies segment leads as it held a market share of 40% in 2022. The growth is attributed to easy shipping and higher availability.

Access the Full Report: Find Detailed Analysis on the Over-The-Counter (OTC) Veterinary Drugs Market

Competitive Landscape:

The key vendors work on a smaller number of side effects, enhanced supply chain, and higher affordability.  Companies also collaborate to expand their supply chain. Key competitors and also merge, acquire, and partner with other companies to increase their supply chain, and distribution channel.

Recent Market Development:

  • Boehringer Ingelheim has introduced new products such as aftopor/aftovaxpur/aftovax, Arti-Cell FORTE, Aservo EquiHaler, and Bovela. and dairy cattle.
  • Phibro Animal Health Corporation has revisited their OTC veterinary drugs for swine, beef cattle.

Key Players:

  • Zoetis
  • Boehringer Ingelheim
  • Virbac S.A.
  • Hester Biosciences Ltd.
  • Merck Animal Health
  • Elanco Animal Health
  • Ceva Santé Animale
  • Vetoquinol S.A.
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • Kyoritsu Seiyaku Corporation
  • AlphaVet Animal Health Ltd.
  • AdvaCare Pharma
  • Alphafacts Health Solution
  • Bimeda Animal Health Inc.

Key Segments Covered:

By Drug Class:

  • NSAIDs
  • Antihistamines
  • Decongestants & Bronchodilators
  • Antibacterial
  • H2 Receptor Antagonists
  • Nutrients & Supplements
  • Glucocorticoids
  • Lubricant eye drops & artificial tears
  • Anti-parasitic
  • Antidiarrheal agents
  • Others

By Product Form:

  • Oral
  • Injectable
  • Topical
  • Others

By Sales Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Retail Pharmacies
  • Hypermarkets & Supermarkets
  • Online Pharmacies
  • Veterinary Shops

Key Regions Covered:

  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *